Dario Prais

VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

Jane C. Davies, Samuel M. Moskowitz, Cynthia D. Brown et al. · New England Journal of Medicine · 2018 · 320 citations · Full text

Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection

Dario Prais · Archives of Disease in Childhood · 2003 · 141 citations · Full text

Increasing nontuberculous mycobacteria infection in cystic fibrosis

O. Baron, Huda Mussaffi, Meir Mei‐Zahav et al. · Journal of Cystic Fibrosis · 2014 · 135 citations · Full text

Medical Microbiology, Pathogenic Microbiology, Microbiology +3

Long COVID in Children

Liat Ashkenazi‐Hoffnung, Einat Shmueli, Shay Ehrlich et al. · The Pediatric Infectious Disease Journal · 2021 · 130 citations · Full text

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for <i>F508del</i> and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study

Marcus Mall, Rossa Brugha, Silvia Gärtner et al. · American Journal of Respiratory and Critical Care Medicine · 2022 · 126 citations · Full text